Thus the definition of mechanisms and downstream mediators of CXCR4/R7 activation by CXCL12, in normal and malignant differentiated cells, their progenitors, and in normal and CSCs, is highly relevant for both cancer biology and perspective therapeutic targeting. The gene discussed is CXCR4; the disease is cancer.